IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Indolent Lymphoma
University of Michigan Rogel Cancer Centermonoclonal_antibodyPhase 2Dormant
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Indolent Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cladribine University of Arizona | Phase 2 | B |
Inno-206 University of Arizona | Phase 2 | B |
Bortezomib University of Arizona | Phase 2 | B |
Cyclophosphamide University of Arizona | Phase 2 | B |
DEXAMETHASONE University of Arizona | Phase 2 | B |
View all 22 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →